• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Bayer AG

Bayer AG

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Research and Markets: Kidney Cancer Drugs (Afinitor, Avastin, Inlyta, Nexavar, Proleukin, Sutent, Torisel, Votrient) Market - Global Industry Analysis 2014-2020

    Research and Markets: Kidney Cancer Drugs (Afinitor, Avastin, Inlyta, Nexavar, Proleukin, Sutent, Torisel, Votrient) Market - Global Industry Analysis 2014-2020

  2. Research and Markets: Regeneron and Bayer AG's Eylea (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

    Research and Markets: Regeneron and Bayer AG's Eylea (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

  3. Bayer's CEO Injects a Dose of U.S. Risk-Taking

    Bayer's CEO Injects a Dose of U.S. Risk-Taking

  4. At Bayer , A Dose Of US Risk-Taking

    At Bayer , A Dose Of US Risk-Taking

  5. Nektar Therapeutics to Present at the 14th Annual Needham Healthcare Conference

    Nektar Therapeutics to Present at the 14th Annual Needham Healthcare Conference

  6. Regeneron Wins Expanded Approval for Eye Drug Elyea

    Regeneron Wins Expanded Approval for Eye Drug Elyea

  7. Research and Markets: France Sleep Apnea Diagnostic Systems Market Growth Trends 2007-2020

    Research and Markets: France Sleep Apnea Diagnostic Systems Market Growth Trends 2007-2020

  8. Grain Highlights: Top Stories of the Day

    Grain Highlights: Top Stories of the Day

  9. Research and Markets: Bone Metastasis Global Clinical Trials Review, H1, 2015

    Research and Markets: Bone Metastasis Global Clinical Trials Review, H1, 2015

  10. Japan stocks swing down then up, as yen creates headwinds

    Japan stocks swing down then up, as yen creates headwinds

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.